… In addition to steroids, extracorporeal membrane oxygenation has been used in a single
patient with blastomycosis-induced ARDS; however, this did not result in patient survival.[160] …

… Patients with severe extrapulmonary blastomycosis should be treated for at least 12 months
… Corticosteroids have been given to patients with ARDS, with apparent success in two cases (…

… respiratory distress syndrome (ARDS) have a poor prognosis [114]. The use of corticosteroids
in this setting remains controversial and unproven, with data limited to case reports [115]. …

… Mortality was 47% for patients with ARDS and 44% for patients … ARDS than for those without
ARDS (47% vs 6%, P < .0001). The mortality for patients with ARDS treated with steroids (n …

… ARDS in the context of blastomycosis-related ARDS, especially with regard to the use of
corticosteroids. In … male patient who developed ARDS due to pulmonary blastomycosis. The …

… to the recovery time, given the benefit of corticosteroids noted in treatment of ARDS. …
Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature…

… have been used in severe disease complicated by ARDS to dampen the deleterious … for
17 patients with blastomycosis-associated ARDS who received adjunctive steroids was lower …

… of 114 patients with blastomycosis from Indiana, ARDS was … In this report, six of the seven
patients with available clinical … leukemia with use of corticosteroids, and diabetes mellitus with …

… patient was started on a short course of corticosteroids. With the combination of these treatments,
the patient … ARDS due to blastomycosis has a mortality of up to 80% with the standard …

… report and was 2 weeks in another. Corticosteroid therapy is not recommended in the IDSA
… , but my preference is to prescribe corticosteroids in patients who are severely ill with ARDS. …